[KAR-146]发行于2012-06-13时长441分钟出品商是カルマ,KAR-146作品种子搜索下载,[IBW-297]发行于2012-05-11时长119分钟出品商是I.B.WORKS,IBW-297作品种子搜索下载
![[KAR-146][IBW-297]作品及种子搜索下载](/images/load.gif)
[KAR-146]发行于2012-06-13时长441分钟出品商是カルマ,KAR-146作品种子搜索下载,[IBW-297]发行于2012-05-11时长119分钟出品商是I.B.WORKS,IBW-297作品种子搜索下载
The anilino-quinazoline derivative BIBW-2992, which is being developed by Boehringer Ingelheim Corp for the potential treatment of solid tumors, is an oral dual receptor tyrosine kinase inhibitor of human EGF receptor (EGFR) and human epidermal growth factor receptor-2 (HER-2)/neu. EGFR and HER...
Afatinib-d6是氘标记的Afatinib。Afatinib (BIBW 2992) 是一种不可逆的EGFR家族抑制剂。 MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务 我们将采用定制合成服务的方式为您快速提供所需产品和技术服务 Afatinib-d6Chemical Structure ...
Afatinib, BIBW2992, BIBW-2992 中文名称(Chinese Name) 阿法替尼 靶点(Target) HER2, EGFR 通路(Pathway) Protein Tyrosine Kinase--EGFR CAS号(CAS NO.) 850140-72-6 分子式(Formula) C24H25ClFN5O3 分子量(Molecular Weight) 485.94 外观(Appearance) ...
Afatinib (BIBW 2992)阿法替尼 目录号 M1677所有产品仅供科研使用,严禁用于人或动物的治疗等任何其他用途,不为任何个人提供产品和服务 Afatinib (BIBW2992) 是一种不可逆EGFR/HER2抑制剂,对EGFR(wt),EGFR(L858R),EGFR(L858R/T790M)和HER2均有抑制作用,IC50分别为0.5 nM,0.4 nM,10 nM和14 nM。
Afatinib (BIBW 2992) is the second-generation potent and irreversible dual inhibitor of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinase, developed by Boehringer Ingelheim, Germany. It is cap
Nonequilibrium ermodynamics of Non-Ideal Chemical Reaction Networks Francesco Avanzini,∗ Emanuele Penocchio,† Gianmaria Falasco,‡ and Massimiliano Esposito§ Complex Systems and Statistical Mechanics, Department of Physics and Materials Science, University of Luxembourg, L-1511 Luxembourg (Dated: ...